Subscribe to Search results

A briefing was provided to the Parliamentary Under-Secretary of State, copied to the Secretary of State and CMO.

Published on:

Risks to patients from the use of whole blood were said to be negligible, with "no evidence" that any patient had contracted the disease in the UK from this source.

Published on:

A briefing stated that there were at present "a very few haemophiliac patients in South Wales," but that it was "likely that some may have received treatment with Factor 8 which might have been contaminated."

Published on:

At a meeting of the CMO Welsh Office reference was made to the donor whose donations had been used for whole blood transfusion and for the production of concentrate, some of which had "found its way to Wales".

Published on:

At a meeting of the CMO Welsh Office the existing leaflet was said to be liberally distributed at every donor session "it was still thought unsafe to rely upon this as the sole means of weeding out the homosexual population from amongst potential blood donors" and "the matter of a more detailed questionnaire could usefully be pursued."

Published on:

A meeting of the CMO Welsh Office was held "to establish the known facts as they affected the UK in general and Wales in the particular."

Published on:

A Welsh Office representative was invited to attend the meetings of the Advisory Group on Hepatitis and the Working Group on AIDS of the Advisory Committee on the NBTS.

Published on:

A ban on Factor 8 from the US was considered at a meeting on AIDS convened by the Welsh Office, Medical Service Health Professional Group. It was argued that this would cause a reduction in patients treated and the modification of the facility for home treatment.

Published on:

A meeting on AIDS was convened by the Welsh Office, Medical Services Health Professional Group. It was attended by Dr Gareth Crompton, the Chief Medical Officer, and a number of medical officers.

Published on:

Dr David Ferguson-Lewis wrote to the Parliamentary Under-Secretary of State notifying him that the patient at the Cardiff Haemophilia Centre did meet the CDSC definition of AIDS but there was "no cause for precipitate action."

Published on:

Dr David Ferguson-Lewis wrote to the Parliamentary Under-Secretary of State following press reports implicating US blood products in cases of AIDS.

Published on:

The Welsh Office issued advice and took action "on its own account", such as issuing PSM (84)4, asking doctors to inform the Communicable Disease Surveillance Centre of cases of AIDS or Kaposi's sarcoma.

Published on:

Dr J Skone wrote to chief administrative medical officers stating that he was aware of a haemophilia patient suffering from AIDS.

Published on:

Dr Nicol Spence Galbraith wrote to venereologists and dermatologists in England and Wales seeking their "cooperation" in a trial clinical reporting system of Kaposi's sarcoma due to the "inadequacies of existing surveillance systems".

Published on:

Lord Owen told the Inquiry in his oral evidence that one of the first duties of the state was to look after the safety of its population, and that that duty extended to the safety of patients receiving blood or blood products.

Published on:

In his oral evidence about his time as Minister for Health at the DHSS, Lord Owen stated that although the Secretary of State for Northern Ireland would make their own decisions, they would tend never to go against the grain of the decisions taken in England.

Published on:

Dr Mark Winter in his oral evidence to the Inquiry described two cases demonstrating how some people with haemophilia were treated elsewhere than at haemophilia centres and the consequences of treatment in such circumstances where those treating might have had limited understanding of the risks of treatment.

Published on:

A group meeting with patients was held to discuss AIDS. According to Professor Christopher Ludlam's oral evidence, clinicians were still wrestling with the ethics of whether to inform patients about AIDS at this time, but decided to hold the meeting as the Yorkshire Post would publish a story within days.

Published on:

According to Dr Diana Walford's oral evidence, during her time at the Med SEB it was apparent that the transmission of non-A non-B hepatitis from blood products was a significant problem and had the potential to lead to chronic liver disease.

Published on:

According to Dr Diana Walford's oral evidence to the Inquiry, she wrote a minute to Mr Harley and spoke "quite forcibly" about the lack of awareness of the potential that Non-A, Non-B Hepatitis could cause severe chronic disease.

Published on: